| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1B1 ATP6V1B2 HSP90AB4P MCM8 MCM4 RAD54L2 CCT8L2 DDX46 KIF14 KIFC3 ABCG8 DYNC1H1 HSP90AB1 HSP90AB3P KIF21A ABCB8 SMARCA1 KIF4B HSP90AB2P CCT8L1P HELLS | 1.92e-06 | 614 | 208 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 3.40e-06 | 40 | 208 | 6 | GO:0140662 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHA9 CDH23 FAT1 PCDH19 NOTCH2 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRIN1 CELSR2 PCDHGB4 PCDH8 CDH12 | 3.73e-06 | 749 | 208 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | clathrin binding | 4.93e-05 | 63 | 208 | 6 | GO:0030276 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 8.15e-05 | 43 | 208 | 5 | GO:0030280 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 1.08e-04 | 2 | 208 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 1.08e-04 | 2 | 208 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 1.08e-04 | 2 | 208 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 1.08e-04 | 2 | 208 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 1.13e-04 | 73 | 208 | 6 | GO:0044183 | |
| GeneOntologyMolecularFunction | structural molecule activity | RPL10L EPPK1 CLTCL1 MYOM1 KRT27 LAMA1 EMILIN2 KRT80 CLTA ROCK2 COL12A1 KRT18 KRT81 KRT83 KRT86 LAMA4 LAMC2 SPTBN4 KRT75 RIMS1 RPL10 | 4.25e-04 | 891 | 208 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | 3'-5' exonuclease activity | 4.33e-04 | 61 | 208 | 5 | GO:0008408 | |
| GeneOntologyMolecularFunction | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.67e-04 | 62 | 208 | 5 | GO:0016796 | |
| GeneOntologyMolecularFunction | 3'-5'-RNA exonuclease activity | 5.77e-04 | 37 | 208 | 4 | GO:0000175 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 7.07e-04 | 39 | 208 | 4 | GO:0097718 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90AB4P MCM8 MCM4 RAD54L2 DDX46 KIF14 ABCG8 DYNC1H1 HSP90AB1 HSP90AB3P KIF21A ABCB8 HSP90AB2P | 7.61e-04 | 441 | 208 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | RNA exonuclease activity, producing 5'-phosphomonoesters | 7.79e-04 | 40 | 208 | 4 | GO:0016896 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.17e-04 | 70 | 208 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 1.22e-03 | 45 | 208 | 4 | GO:0004532 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.49e-03 | 118 | 208 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 1.69e-03 | 23 | 208 | 3 | GO:0030215 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 2.08e-03 | 126 | 208 | 6 | GO:0051082 | |
| GeneOntologyMolecularFunction | opsonin binding | 2.16e-03 | 25 | 208 | 3 | GO:0001846 | |
| GeneOntologyMolecularFunction | MutSalpha complex binding | 2.19e-03 | 7 | 208 | 2 | GO:0032407 | |
| GeneOntologyMolecularFunction | L-leucine binding | 2.19e-03 | 7 | 208 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 2.19e-03 | 7 | 208 | 2 | GO:0032051 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA9 CDH23 FAT1 PCDH19 CNTN4 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 2.16e-17 | 187 | 208 | 22 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHA9 CDH23 FAT1 PCDH19 CNTN4 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TENM4 CELSR2 PCDHGB4 PCDH8 CDH12 | 1.18e-13 | 313 | 208 | 23 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PCDHA9 EMILIN2 CDH23 FCHO1 FAT1 PCDH19 KIFC3 CNTN4 KRT18 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PLEKHG4B KLHL25 TENM4 CELSR2 BTNL2 PCDHGB4 PCDH8 CDH12 | 4.34e-07 | 1077 | 208 | 30 | GO:0098609 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 7.17e-07 | 99 | 208 | 9 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 7.81e-07 | 100 | 208 | 9 | GO:0045103 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.06e-05 | 75 | 208 | 7 | GO:0045109 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | EPPK1 MYOM1 KRT27 CHRNA7 KRT80 FAT1 KIF14 MICAL3 MYH16 TACC3 MLST8 CORO7 DYNC1H1 HSP90AB1 ROCK2 KRT8 COL12A1 KRT81 KRT83 KRT86 WNT11 HIP1R SPTBN4 CCDC88A KRT75 | 1.31e-05 | 957 | 208 | 25 | GO:0097435 |
| GeneOntologyBiologicalProcess | clathrin coat assembly | 7.65e-05 | 23 | 208 | 4 | GO:0048268 | |
| GeneOntologyCellularComponent | keratin filament | 5.49e-06 | 97 | 207 | 8 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | NES EPPK1 KRT27 KRT80 SYNE2 KRT8 KRT18 KRT81 KRT83 KRT86 KRT75 EXD2 | 1.31e-05 | 263 | 207 | 12 | GO:0045111 |
| GeneOntologyCellularComponent | clathrin vesicle coat | 3.49e-05 | 38 | 207 | 5 | GO:0030125 | |
| GeneOntologyCellularComponent | stereocilium tip | 5.94e-05 | 22 | 207 | 4 | GO:0032426 | |
| GeneOntologyCellularComponent | intermediate filament | 9.28e-05 | 227 | 207 | 10 | GO:0005882 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.43e-04 | 80 | 207 | 6 | GO:0005905 | |
| GeneOntologyCellularComponent | clathrin coat | 2.30e-04 | 56 | 207 | 5 | GO:0030118 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic active zone membrane | 2.91e-04 | 3 | 207 | 2 | GO:0098891 | |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 3.21e-04 | 14 | 207 | 3 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 3.21e-04 | 14 | 207 | 3 | GO:0060091 | |
| GeneOntologyCellularComponent | actin-based cell projection | ATP6V1B1 ATP6V1B2 RAPH1 CDH23 FAT1 SYNE2 STRC DYNC1H1 STRCP1 PKHD1L1 | 4.73e-04 | 278 | 207 | 10 | GO:0098858 |
| GeneOntologyCellularComponent | extrinsic component of membrane | ATP6V1B1 ATP6V1B2 ATR CDH23 PHB1 PIK3R4 PLEKHG4B RIMS1 CDH12 | 4.96e-04 | 230 | 207 | 9 | GO:0019898 |
| GeneOntologyCellularComponent | vesicle coat | 5.32e-04 | 67 | 207 | 5 | GO:0030120 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 6.15e-04 | 237 | 207 | 9 | GO:0030136 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 6.67e-04 | 147 | 207 | 7 | GO:0030665 | |
| GeneOntologyCellularComponent | protein folding chaperone complex | 7.79e-04 | 42 | 207 | 4 | GO:0101031 | |
| GeneOntologyCellularComponent | ATP-binding cassette (ABC) transporter complex | 1.43e-03 | 6 | 207 | 2 | GO:0043190 | |
| HumanPheno | Perifollicular hyperkeratosis | 1.12e-05 | 4 | 73 | 3 | HP:0007468 | |
| Domain | Cadherin_CS | PCDHA9 CDH23 FAT1 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 8.73e-21 | 109 | 199 | 21 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA9 CDH23 FAT1 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 1.94e-20 | 113 | 199 | 21 | PS00232 |
| Domain | Cadherin | PCDHA9 CDH23 FAT1 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 1.94e-20 | 113 | 199 | 21 | PF00028 |
| Domain | CADHERIN_2 | PCDHA9 CDH23 FAT1 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 2.36e-20 | 114 | 199 | 21 | PS50268 |
| Domain | - | PCDHA9 CDH23 FAT1 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 2.36e-20 | 114 | 199 | 21 | 2.60.40.60 |
| Domain | CA | PCDHA9 CDH23 FAT1 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 2.86e-20 | 115 | 199 | 21 | SM00112 |
| Domain | Cadherin-like | PCDHA9 CDH23 FAT1 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 3.46e-20 | 116 | 199 | 21 | IPR015919 |
| Domain | Cadherin | PCDHA9 CDH23 FAT1 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 CDH12 | 5.03e-20 | 118 | 199 | 21 | IPR002126 |
| Domain | Cadherin_2 | PCDHA9 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 PCDH8 | 1.76e-19 | 65 | 199 | 17 | PF08266 |
| Domain | Cadherin_N | PCDHA9 PCDH19 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 PCDH8 | 1.76e-19 | 65 | 199 | 17 | IPR013164 |
| Domain | Cadherin_tail | PCDHA9 PCDHGA9 PCDHGA3 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 7.54e-19 | 37 | 199 | 14 | PF15974 |
| Domain | Cadherin_CBD | PCDHA9 PCDHGA9 PCDHGA3 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 7.54e-19 | 37 | 199 | 14 | IPR031904 |
| Domain | Filament | 6.22e-08 | 71 | 199 | 9 | SM01391 | |
| Domain | IF | 7.04e-08 | 72 | 199 | 9 | PS00226 | |
| Domain | Filament | 7.96e-08 | 73 | 199 | 9 | PF00038 | |
| Domain | IF | 1.14e-07 | 76 | 199 | 9 | IPR001664 | |
| Domain | Keratin_II | 2.62e-07 | 26 | 199 | 6 | IPR003054 | |
| Domain | ENTH | 1.51e-06 | 9 | 199 | 4 | PS50942 | |
| Domain | ENTH | 1.51e-06 | 9 | 199 | 4 | SM00273 | |
| Domain | ENTH | 2.50e-06 | 10 | 199 | 4 | IPR013809 | |
| Domain | Intermediate_filament_CS | 4.68e-06 | 63 | 199 | 7 | IPR018039 | |
| Domain | Keratin_2_head | 4.71e-06 | 24 | 199 | 5 | IPR032444 | |
| Domain | Keratin_2_head | 4.71e-06 | 24 | 199 | 5 | PF16208 | |
| Domain | Cadherin_C | 5.17e-06 | 42 | 199 | 6 | IPR032455 | |
| Domain | Cadherin_C_2 | 5.17e-06 | 42 | 199 | 6 | PF16492 | |
| Domain | ENTH | 2.33e-05 | 6 | 199 | 3 | PF01417 | |
| Domain | UIM | 3.40e-05 | 18 | 199 | 4 | PF02809 | |
| Domain | UIM | 6.49e-05 | 21 | 199 | 4 | SM00726 | |
| Domain | UIM | 1.12e-04 | 24 | 199 | 4 | PS50330 | |
| Domain | ELFV_dehydrog_N | 1.13e-04 | 2 | 199 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 1.13e-04 | 2 | 199 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 1.13e-04 | 2 | 199 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 1.13e-04 | 2 | 199 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 1.13e-04 | 2 | 199 | 2 | PF00208 | |
| Domain | Ribosomal_L10e_CS | 1.13e-04 | 2 | 199 | 2 | IPR018255 | |
| Domain | NAD_bind_Glu_DH | 1.13e-04 | 2 | 199 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 1.13e-04 | 2 | 199 | 2 | PS00074 | |
| Domain | ELFV_dehydrog | 1.13e-04 | 2 | 199 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 1.13e-04 | 2 | 199 | 2 | IPR033524 | |
| Domain | V-ATPase_su_B/beta | 1.13e-04 | 2 | 199 | 2 | IPR022879 | |
| Domain | Ribosomal_L10e | 1.13e-04 | 2 | 199 | 2 | IPR001197 | |
| Domain | RIBOSOMAL_L10E | 1.13e-04 | 2 | 199 | 2 | PS01257 | |
| Domain | ATPase_V1-cplx_bsu | 1.13e-04 | 2 | 199 | 2 | IPR005723 | |
| Domain | UIM_dom | 1.33e-04 | 25 | 199 | 4 | IPR003903 | |
| Domain | - | 1.56e-04 | 26 | 199 | 4 | 1.25.40.90 | |
| Domain | ENTH_VHS | 2.41e-04 | 29 | 199 | 4 | IPR008942 | |
| Domain | EGF_LAM_2 | 2.76e-04 | 30 | 199 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 2.76e-04 | 30 | 199 | 4 | PS01248 | |
| Domain | RIBONUCLEASE_II | 3.36e-04 | 3 | 199 | 2 | PS01175 | |
| Domain | Rrp44_CSD1 | 3.36e-04 | 3 | 199 | 2 | PF17216 | |
| Domain | Rrp44_CSD1 | 3.36e-04 | 3 | 199 | 2 | IPR033771 | |
| Domain | Ribosomal_L10e/L16 | 3.36e-04 | 3 | 199 | 2 | IPR016180 | |
| Domain | - | 3.36e-04 | 3 | 199 | 2 | 3.90.1170.10 | |
| Domain | Ribosomal_L16 | 3.36e-04 | 3 | 199 | 2 | PF00252 | |
| Domain | Laminin_G | 3.78e-04 | 58 | 199 | 5 | IPR001791 | |
| Domain | EGF_Lam | 5.06e-04 | 35 | 199 | 4 | SM00180 | |
| Domain | Laminin_EGF | 5.06e-04 | 35 | 199 | 4 | PF00053 | |
| Domain | RNase_II/R_CS | 6.68e-04 | 4 | 199 | 2 | IPR022966 | |
| Domain | Rubredoxin-type_fold | 6.68e-04 | 4 | 199 | 2 | IPR004039 | |
| Domain | - | 6.68e-04 | 4 | 199 | 2 | 2.20.28.10 | |
| Domain | LAM_G_DOMAIN | 6.95e-04 | 38 | 199 | 4 | PS50025 | |
| Domain | Laminin_EGF | 6.95e-04 | 38 | 199 | 4 | IPR002049 | |
| Domain | Laminin_G_2 | 8.46e-04 | 40 | 199 | 4 | PF02210 | |
| Domain | Kinesin_motor_CS | 9.30e-04 | 41 | 199 | 4 | IPR019821 | |
| Domain | ATP_synth_asu_C | 1.11e-03 | 5 | 199 | 2 | IPR000793 | |
| Domain | Anaphylatoxin_comp_syst | 1.11e-03 | 5 | 199 | 2 | IPR018081 | |
| Domain | Laminin_domII | 1.11e-03 | 5 | 199 | 2 | IPR010307 | |
| Domain | ATP-synt_ab_N | 1.11e-03 | 5 | 199 | 2 | PF02874 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.11e-03 | 5 | 199 | 2 | IPR001840 | |
| Domain | ATPase_F1/V1/A1_a/bsu_N | 1.11e-03 | 5 | 199 | 2 | IPR004100 | |
| Domain | Laminin_aI | 1.11e-03 | 5 | 199 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.11e-03 | 5 | 199 | 2 | PF06008 | |
| Domain | Laminin_II | 1.11e-03 | 5 | 199 | 2 | PF06009 | |
| Domain | ATPase_a/bsu_AS | 1.11e-03 | 5 | 199 | 2 | IPR020003 | |
| Domain | ATP-synt_ab_C | 1.11e-03 | 5 | 199 | 2 | PF00306 | |
| Domain | ATP-synt_ab | 1.11e-03 | 5 | 199 | 2 | PF00006 | |
| Domain | ATPASE_ALPHA_BETA | 1.11e-03 | 5 | 199 | 2 | PS00152 | |
| Domain | Kinesin-like_fam | 1.11e-03 | 43 | 199 | 4 | IPR027640 | |
| Domain | Semaphorin | 1.19e-03 | 20 | 199 | 3 | IPR027231 | |
| Domain | - | 1.22e-03 | 44 | 199 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 1.22e-03 | 44 | 199 | 4 | PF00225 | |
| Domain | KISc | 1.22e-03 | 44 | 199 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.22e-03 | 44 | 199 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.22e-03 | 44 | 199 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.22e-03 | 44 | 199 | 4 | PS50067 | |
| Domain | LamG | 1.22e-03 | 44 | 199 | 4 | SM00282 | |
| Domain | ANK_REPEAT | ANKRD20A2P ANKRD20A3P ANKRD20A4P PLA2G6 ANKRD20A1 NOTCH2 MUC16 ANKRD13A MYO16 | 1.61e-03 | 253 | 199 | 9 | PS50088 |
| Domain | ATPase_F1/V1/A1_a/bsu_nucl-bd | 1.65e-03 | 6 | 199 | 2 | IPR000194 | |
| Domain | ANK_REP_REGION | ANKRD20A2P ANKRD20A3P ANKRD20A4P PLA2G6 ANKRD20A1 NOTCH2 MUC16 ANKRD13A MYO16 | 1.65e-03 | 254 | 199 | 9 | PS50297 |
| Domain | - | 1.73e-03 | 207 | 199 | 8 | 1.25.40.10 | |
| Domain | Ankyrin_rpt | RAPH1 ANKRD20A2P ANKRD20A3P ANKRD20A4P PLA2G6 ANKRD20A1 NOTCH2 ANKRD13A MYO16 | 2.04e-03 | 262 | 199 | 9 | IPR002110 |
| Domain | ANATO | 2.29e-03 | 7 | 199 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 2.29e-03 | 7 | 199 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.29e-03 | 7 | 199 | 2 | PS01177 | |
| Domain | ANATO | 2.29e-03 | 7 | 199 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 2.29e-03 | 7 | 199 | 2 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 3.03e-03 | 8 | 199 | 2 | IPR019565 | |
| Domain | MCM_OB | 3.03e-03 | 8 | 199 | 2 | PF17207 | |
| Domain | VDCC_gsu | 3.03e-03 | 8 | 199 | 2 | IPR008368 | |
| Domain | MCM_OB | 3.03e-03 | 8 | 199 | 2 | IPR033762 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.91e-06 | 87 | 150 | 8 | MM15351 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT27 KRT80 CACNG3 CACNG2 SEMA6D CLTA HSP90AB1 ROCK2 KRT8 RARS1 KRT18 KRT81 KRT83 KRT86 GRIN1 SPTBN4 KRT75 KIF4B | 6.43e-06 | 502 | 150 | 18 | MM14537 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | RPL10L ATP6V1B2 DIS3L2 CLTCL1 KRT27 PSMB2 LAMA1 KRT80 CACNG3 CACNG2 SEMA6D PCDH19 CLTA SCN9A MED21 HSP90AB1 ROCK2 CACNA1C KRT8 RARS1 KRT18 KRT81 CNOT10 KRT83 KRT86 WNT11 GRIN1 SPTBN4 KRT75 KIF4B PSME3 RPL10 | 3.68e-05 | 1432 | 150 | 32 | M509 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 7.01e-05 | 129 | 150 | 8 | M27649 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA9 PCDHGA9 PCDHGA3 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 2.35e-24 | 28 | 212 | 14 | 15347688 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA9 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 | 1.16e-22 | 72 | 212 | 17 | 10380929 |
| Pubmed | PCDHA9 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 | 4.10e-22 | 77 | 212 | 17 | 10835267 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.44e-22 | 15 | 212 | 11 | 15640798 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA9 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CELSR2 PCDHGB4 PCDH8 | 8.35e-22 | 80 | 212 | 17 | 10716726 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA9 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 PCDH8 | 2.27e-21 | 68 | 212 | 16 | 11230163 |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.98e-21 | 17 | 212 | 11 | 29911975 | |
| Pubmed | PCDHA9 PCDHGA3 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.87e-21 | 24 | 212 | 12 | 24698270 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA9 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 6.35e-21 | 57 | 212 | 15 | 32633719 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA9 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 PCDH8 | 1.01e-20 | 74 | 212 | 16 | 10817752 |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.02e-20 | 18 | 212 | 11 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.02e-20 | 18 | 212 | 11 | 10662547 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 5.07e-19 | 58 | 212 | 14 | 30377227 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 2.71e-16 | 11 | 212 | 8 | 9655502 | |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 2.18e-13 | 12 | 212 | 7 | 10612399 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.16e-12 | 75 | 212 | 11 | 15372022 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | RPL10L EPPK1 PSMB2 MCM4 PHB1 CKMT2 FAM120A GLUD1 GLUD2 DYNC1H1 HSP90AB1 HSP90AB3P RARS1 KRT18 RPL10 | 6.67e-11 | 256 | 212 | 15 | 35777956 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.97e-10 | 119 | 212 | 11 | 28625976 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES ATP6V1B2 EPPK1 ACLY MCM4 KRT80 PHB1 CEP350 URB1 DDX46 SYNE2 GLUD1 CLTA KIF14 DYNC1H1 STOML2 HSP90AB1 RARS1 KRT18 NPEPPS KRT86 BBS7 EXD2 CSTF3 RPL10 HELLS | 9.59e-10 | 1024 | 212 | 26 | 24711643 |
| Pubmed | PCDHA9 EFS EXTL3 URB1 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA3 PCDHA2 PCDHA1 CELSR2 SLC22A3 RIMS1 | 2.14e-09 | 329 | 212 | 15 | 17474147 | |
| Pubmed | PCDHA9 ZFAT PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.88e-09 | 193 | 212 | 12 | 22589738 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 4.52e-09 | 90 | 212 | 9 | 35654790 | |
| Pubmed | 4.85e-09 | 63 | 212 | 8 | 16831889 | ||
| Pubmed | NES ATP6V1B2 ACLY PIK3R4 FAM120A GLUD1 GLUD2 C4A MICAL3 C4B CORO7 GOLGA3 DYNC1H1 STOML2 HSP90AB1 ROCK2 ARHGAP23 WFS1 NPEPPS RBP3 GRIN1 EPN2 SPTBN4 ARHGAP5 TENM4 MAST1 RIMS1 RPL10 DNPEP | 1.54e-08 | 1431 | 212 | 29 | 37142655 | |
| Pubmed | 1.99e-08 | 6 | 212 | 4 | 25122462 | ||
| Pubmed | ATR MCM8 RAD54L2 PIK3R4 SLC25A32 FAM120A GLB1 C4A MICAL3 C4B EPN1 ARHGAP23 LAMC2 DIS3 CCDC88A LRCH4 OGFOD1 RUBCN HELLS | 2.22e-08 | 650 | 212 | 19 | 38777146 | |
| Pubmed | ATP6V1B2 EPPK1 HSP90AB4P ACLY BIRC6 FAT1 FAM120A GLB1 RAD1 SYNE2 CLTA MLST8 DYNC1H1 NOTCH2 HSP90AB1 ROCK2 MARS2 COL12A1 RARS1 KRT18 KIF21A USP24 LAMP2 ABHD17B RPL10 DNPEP HELLS | 2.94e-08 | 1297 | 212 | 27 | 33545068 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | HSP90AB4P ACLY PHB1 DYNC1H1 STOML2 HSP90AB1 HSP90AB3P RARS1 NPEPPS USP24 EXD2 PSME3 HSP90AB2P RPL10 | 3.10e-08 | 344 | 212 | 14 | 36282215 |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 3.32e-08 | 16 | 212 | 5 | 12399393 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPPK1 RAPH1 ACLY PSMB2 MCM4 BIRC6 ISY1 PHB1 DDX46 SYNE2 GLUD1 DYNC1H1 HSP90AB1 ROCK2 KRT8 RARS1 KRT18 KIF21A WNT11 USP24 DIS3 KRT75 PSME3 HSP90AB2P EIF3F RPL10 DNPEP HELLS | 4.61e-08 | 1415 | 212 | 28 | 28515276 |
| Pubmed | RPL10L ABHD15 CLTCL1 ACLY PSMB2 MCM4 BIRC6 PHB1 CEP350 PIK3R4 FAM120A CLTA KIF14 CORO7 GOLGA3 DYNC1H1 NOTCH2 HSP90AB1 RARS1 CNOT10 DIS3 ABHD17B PSME3 EIF3F RPL10 | 5.89e-08 | 1168 | 212 | 25 | 19946888 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 9.22e-08 | 8 | 212 | 4 | 12634303 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.04e-07 | 170 | 212 | 10 | 23314748 | |
| Pubmed | RPL10L CLTCL1 KRT27 ACLY PSMB2 MCM4 AK7 KRT80 PHB1 DDX46 FAM120A GLB1 CLTA DYNC1H1 HSP90AB1 HSP90AB3P KRT8 RARS1 KRT18 USF3 KRT75 HSP90AB2P EIF3F RPL10 | 1.84e-07 | 1153 | 212 | 24 | 29845934 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSP90AB4P ATR ACLY PSMB2 MCM4 PHB1 PIK3R4 URB1 FAM120A GLUD1 CLTA KIF14 DYNC1H1 STOML2 HSP90AB1 MARS2 RARS1 NPEPPS DIS3 PDE12 DNAJC11 SMARCA1 CSTF3 PSME3 RPL10 DNPEP HELLS | 1.94e-07 | 1425 | 212 | 27 | 30948266 |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 2.23e-07 | 3 | 212 | 3 | 25557232 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 2.23e-07 | 3 | 212 | 3 | 1372089 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 1712823 | ||
| Pubmed | RPL10L SPAG1 CLTCL1 RAPH1 RAD54L2 PHB1 PHEX SYNE2 GLUD1 GLUD2 SCN9A HSP90AB1 ROCK2 CACNA1C KRT8 KRT18 PCDHGA9 PCDHGA3 KIF21A SPTBN4 KRT75 DNAJC11 PCDHGB4 SMARCA1 CFAP74 RIMS1 RPL10 | 2.45e-07 | 1442 | 212 | 27 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES DIS3L2 ACLY PSMB2 MCM4 BIRC6 PHB1 PIK3R4 URB1 FAM120A CORO7 DYNC1H1 STOML2 HSP90AB1 RARS1 KRT18 ARHGAP23 NPEPPS KIF21A HIP1R DIS3 PDE12 SMARCA1 PSME3 HSP90AB2P EIF3F | 2.55e-07 | 1353 | 212 | 26 | 29467282 |
| Pubmed | ATP6V1B2 ACLY PSMB2 MCM4 PHB1 GLUD1 CLTA EPN1 DYNC1H1 HSP90AB1 KRT8 RARS1 KRT18 KRT81 HIP1R PSME3 EIF3F RPL10 | 4.04e-07 | 707 | 212 | 18 | 19738201 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | RPL10L HSP90AB4P MCM4 PHB1 GLB1 DYNC1H1 STOML2 HSP90AB1 HSP90AB3P RARS1 NPEPPS DIS3 EXD2 DNAJC11 HSP90AB2P RPL10 | 4.55e-07 | 565 | 212 | 16 | 33567341 |
| Pubmed | NES CACNG2 FAM120A KLHL7 SYNE2 TACC3 GOLGA3 DYNC1H1 STOML2 HSP90AB1 ROCK2 CNTN4 NPEPPS KIF21A GRIN1 SPTBN4 CCDC88A CELSR2 KIF4B RIMS1 PCDH8 | 5.36e-07 | 963 | 212 | 21 | 28671696 | |
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 6.39e-07 | 12 | 212 | 4 | 10692104 | |
| Pubmed | RPL10L ATP6V1B2 ACLY PSMB2 MCM4 ISY1 FAM120A GLUD1 CLTA MED21 DYNC1H1 STOML2 HSP90AB1 ROCK2 RARS1 KRT18 WFS1 PPFIBP2 NPEPPS KIF21A DIS3 DNAJC11 RPL10 HELLS | 7.45e-07 | 1247 | 212 | 24 | 27684187 | |
| Pubmed | The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion. | 8.89e-07 | 4 | 212 | 3 | 20709745 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 15797458 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NES SPAG1 EPPK1 PSMB2 KRT80 PHB1 DDX46 SYNE2 GLUD1 CLTA TACC3 STOML2 HSP90AB1 ROCK2 KRT18 NPEPPS KIF21A HIP1R LAMP2 DIS3 ANKRD13A PDE12 CSTF3 PSME3 RPL10 | 1.09e-06 | 1367 | 212 | 25 | 32687490 |
| Pubmed | RPL10L NES EPPK1 PSMB2 MCM4 GLUD1 GLUD2 KIF14 C4A C4B DYNC1H1 HSP90AB1 RARS1 KRT18 MUC16 HSP90AB2P EIF3F RPL10 DNPEP | 1.20e-06 | 844 | 212 | 19 | 25963833 | |
| Pubmed | ADGRB1 BIRC6 PHB1 CACNG3 CACNG2 GLUD1 CLTA GLUD2 STOML2 HSP90AB1 RARS1 WFS1 USP24 HIP1R GRIN1 CCDC88A TENM4 CELSR2 DNAJC11 RIMS1 PCDH8 RPL10 | 2.10e-06 | 1139 | 212 | 22 | 36417873 | |
| Pubmed | SEMA6D GLB1 PCDH19 MICAL3 GOLGA3 NOTCH2 ROCK2 EPN2 ARHGAP5 CCDC88A CELSR2 STX10 USP6NL | 2.19e-06 | 421 | 212 | 13 | 36976175 | |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 34888534 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 24920589 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | RPL10L EPPK1 CLTCL1 CEP350 FAT1 FAM120A GLB1 GOLGA3 STOML2 HSP90AB1 RARS1 LAMP2 CCDC88A SSX2IP PSME3 RPL10 | 2.25e-06 | 639 | 212 | 16 | 23443559 |
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 2.31e-06 | 16 | 212 | 4 | 16269234 | |
| Pubmed | 2.31e-06 | 16 | 212 | 4 | 17601529 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MYOM1 RAPH1 CDH23 FCHO1 FAT1 DDX46 KIF14 KRT8 PPFIBP2 SPTBN4 MTBP HSP90AB2P | 2.55e-06 | 361 | 212 | 12 | 26167880 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPPK1 CLTCL1 ACLY PSMB2 ACE PHB1 DYNC1H1 STOML2 HSP90AB1 KRT8 RARS1 NPEPPS PCDHA8 PSME3 EIF3F MYO16 RPL10 DNPEP | 2.63e-06 | 807 | 212 | 18 | 30575818 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPPK1 CLTCL1 ACLY PSMB2 MCM4 KRT80 PHB1 DYNC1H1 STOML2 RARS1 KRT18 NPEPPS ANKRD13A ABCB8 EIF3F RPL10 | 2.64e-06 | 647 | 212 | 16 | 26618866 |
| Pubmed | NES EPPK1 ACLY MCM4 BIRC6 URB1 DDX46 FAM120A SYNE2 KIF14 DYNC1H1 STOML2 NPEPPS USP24 DIS3 RPL10 | 2.97e-06 | 653 | 212 | 16 | 22586326 | |
| Pubmed | HSP90AB4P DYNC1H1 HSP90AB1 RARS1 NPEPPS LAMP2 CCDC88A HSP90AB2P | 3.25e-06 | 145 | 212 | 8 | 23349634 | |
| Pubmed | 3.84e-06 | 18 | 212 | 4 | 36280666 | ||
| Pubmed | ATP6V1B2 HIPK1 EXTL3 RAD54L2 CEP350 PIK3R4 FAM120A KLHL7 GLUD1 PRMT2 KIFC3 MLST8 GOLGA3 DYNC1H1 HSP90AB1 CNTN4 KRT83 KIF21A SPTBN4 ARHGAP5 MAST1 SPRED1 EIF3F | 4.30e-06 | 1285 | 212 | 23 | 35914814 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.35e-06 | 256 | 212 | 10 | 33397691 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 15671067 | ||
| Pubmed | Epiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganization. | 4.41e-06 | 6 | 212 | 3 | 25617501 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP6V1B2 CLTCL1 HSP90AB4P PSMB2 MCM4 PHB1 CLTA DYNC1H1 HSP90AB1 HSP90AB3P ROCK2 GINS3 RARS1 KIF21A DNAJC11 HSP90AB2P EIF3F RPL10 | 5.13e-06 | 847 | 212 | 18 | 35235311 |
| Pubmed | 5.68e-06 | 42 | 212 | 5 | 27578003 | ||
| Pubmed | Proteomic identification of brain proteins that interact with dynein light chain LC8. | 5.68e-06 | 42 | 212 | 5 | 14760703 | |
| Pubmed | RPL10L PSMB2 MCM4 ISY1 DDX46 CLTA DYNC1H1 HSP90AB1 HSP90AB3P KRT8 KRT18 KIF4B HSP90AB2P RPL10 | 6.37e-06 | 538 | 212 | 14 | 28524877 | |
| Pubmed | ATP6V1B2 RAPH1 PSMB2 BIRC6 CEP350 SYNE2 CLTA PLCL2 KIF14 MICAL3 STOML2 HSP90AB1 KRT8 KRT18 ARHGAP5 CCDC88A SSX2IP CSTF3 INTS4 HELLS | 7.56e-06 | 1049 | 212 | 20 | 27880917 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPPK1 ATR ACLY MCM4 C4A C4B TACC3 DYNC1H1 HSP90AB1 RARS1 NPEPPS DIS3 RPL10 | 8.42e-06 | 477 | 212 | 13 | 31300519 |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 8.42e-06 | 118 | 212 | 7 | 19156168 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ATP6V1B1 HSP90AB4P ATR EXTL3 PHB1 FAT1 EPN1 NOTCH2 STOML2 WFS1 NPEPPS PCDHA12 PCDHA4 DIS3 EPN2 CELSR2 ABCB8 INTS4 PSME3 STX10 | 8.92e-06 | 1061 | 212 | 20 | 33845483 |
| Pubmed | 8.98e-06 | 46 | 212 | 5 | 37207277 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPL10L ACLY MCM4 ISY1 PTK6 PHB1 FAM120A GLUD1 DYNC1H1 STOML2 HSP90AB1 LAMP2 DIS3 HSP90AB2P EIF3F RPL10 | 9.09e-06 | 714 | 212 | 16 | 28302793 |
| Pubmed | HSP90AB4P ACLY MCM4 PHB1 DDX46 DYNC1H1 HSP90AB1 RARS1 USP24 DIS3 CSTF3 PSME3 EIF3F RPL10 HELLS | 9.95e-06 | 638 | 212 | 15 | 33239621 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ACLY PSMB2 MCM4 BIRC6 PHB1 PIK3R4 URB1 GLUD1 GLUD2 DYNC1H1 STOML2 HSP90AB1 RARS1 NPEPPS DIS3 EXD2 DNAJC11 PSME3 HSP90AB2P EIF3F RPL10 HELLS | 9.98e-06 | 1257 | 212 | 22 | 37317656 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ATP6V1B1 ATP6V1B2 CLTCL1 KRT27 ACLY PSMB2 ACE GLB1 C4A C4B DYNC1H1 HSP90AB1 HSP90AB3P KRT8 NPEPPS LAMP2 SPTBN4 KRT75 HSP90AB2P UEVLD | 1.01e-05 | 1070 | 212 | 20 | 23533145 |
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | SPAG1 HSP90AB4P PSMB2 EXTL3 PHB1 HSP90AB3P NPEPPS EXD2 DNAJC11 PLD5 | 1.01e-05 | 282 | 212 | 10 | 35007762 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ATP6V1B2 ACLY PSMB2 MCM4 BIRC6 EPN1 DYNC1H1 HSP90AB1 ROCK2 GINS3 RARS1 KRT18 NPEPPS KIF21A USP24 LAMP2 DIS3 PDE12 OGFOD1 PSME3 HSP90AB2P EIF3F RPL10 DNPEP | 1.03e-05 | 1455 | 212 | 24 | 22863883 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPAG1 RAPH1 GOLGA3 NOTCH2 HSP90AB1 EPN3 RARS1 KRT18 ARHGAP23 EPN2 TTC7A ARHGAP5 SPRED1 USP6NL | 1.10e-05 | 565 | 212 | 14 | 25468996 |
| Pubmed | BIRC6 FCHO1 ISY1 CEP350 FAM120A ZNF286B MICAL3 ROCK2 CNTN4 ARHGAP23 EPN2 USF3 SSX2IP | 1.19e-05 | 493 | 212 | 13 | 15368895 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 1.22e-05 | 8 | 212 | 3 | 21165971 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | TOPAZ1 PHB1 PIK3R4 DDX46 SCN9A C4A MICAL3 C4B CACNA1C NPEPPS PCDHB6 DNPEP HELLS | 1.30e-05 | 497 | 212 | 13 | 36774506 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TOPAZ1 ACLY LAMA1 ADGRB1 ANKRD20A3P BIRC6 URB1 DYNC1H1 HSP90AB1 RARS1 KIF21A PCDHA5 GRIN1 ARHGAP5 PDE12 RPL10 | 1.32e-05 | 736 | 212 | 16 | 29676528 |
| Pubmed | Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne. | 1.36e-05 | 50 | 212 | 5 | 31699778 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | EPPK1 MCM4 SEMA6D SYNE2 DYNC1H1 NOTCH2 SEMA6C RARS1 CNOT10 WNT11 CELSR2 | 1.40e-05 | 358 | 212 | 11 | 32460013 |
| Pubmed | RPL10L NES EPPK1 RAPH1 ACLY PSMB2 GLUD1 CLTA STOML2 ARHGAP23 KRT81 KRT86 PHETA1 PLEKHG4B ARHGAP5 DNAJC11 LRCH4 PSME3 | 1.47e-05 | 916 | 212 | 18 | 32203420 | |
| Pubmed | HIPK1 PLCL2 EPN1 DYNC1H1 NOTCH2 EPN3 KRT81 LAMA4 EPN2 ANKRD13A ARHGAP5 SPRED1 EIF3F RUBCN | 1.82e-05 | 591 | 212 | 14 | 15231748 | |
| Pubmed | 1.83e-05 | 9 | 212 | 3 | 36871220 | ||
| Pubmed | 1.83e-05 | 9 | 212 | 3 | 12154121 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ACLY PSMB2 PHB1 URB1 GLB1 CORO7 DYNC1H1 HSP90AB1 RARS1 KRT18 WFS1 USP24 ANKRD13A PDE12 EXD2 DNAJC11 CSTF3 HELLS | 2.13e-05 | 942 | 212 | 18 | 31073040 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SPAG1 CDH23 MCM4 FBXO30 PHB1 GLB1 KLHL7 CLTA PLCL2 MLST8 DYNC1H1 STOML2 HSP90AB3P ROCK2 CNOT10 DIS3 EPN2 ANKRD13A CCDC88A BBS7 HSP90AB2P DNPEP | 2.13e-05 | 1321 | 212 | 22 | 27173435 |
| Pubmed | ATP6V1B2 ACLY KRT80 PHB1 MLST8 DYNC1H1 HSP90AB1 KRT8 RARS1 KRT86 | 2.42e-05 | 312 | 212 | 10 | 37120454 | |
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 2.45e-05 | 28 | 212 | 4 | 33523829 | |
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | PSMB2 LAMA1 BIRC6 PHB1 STOML2 RARS1 ANKRD13A PDE12 PSME3 EIF3F | 2.48e-05 | 313 | 212 | 10 | 16196087 |
| Pubmed | 2.49e-05 | 94 | 212 | 6 | 32062451 | ||
| Pubmed | 2.60e-05 | 10 | 212 | 3 | 11784026 | ||
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 2.60e-05 | 10 | 212 | 3 | 20976766 | |
| Interaction | PCDHA10 interactions | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 6.41e-15 | 22 | 208 | 10 | int:PCDHA10 |
| Interaction | PCDHA8 interactions | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FRMD5 | 2.16e-10 | 55 | 208 | 10 | int:PCDHA8 |
| Interaction | PCDHA7 interactions | 3.15e-09 | 14 | 208 | 6 | int:PCDHA7 | |
| Interaction | FLT3 interactions | PCDHA9 EPPK1 URB1 DYNC1H1 RARS1 NPEPPS PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 HELLS | 3.68e-08 | 318 | 208 | 17 | int:FLT3 |
| Interaction | PCDHA11 interactions | 1.15e-06 | 19 | 208 | 5 | int:PCDHA11 | |
| Interaction | PCDHA1 interactions | 1.33e-06 | 9 | 208 | 4 | int:PCDHA1 | |
| Interaction | KRT25 interactions | 1.42e-06 | 35 | 208 | 6 | int:KRT25 | |
| Interaction | KRT35 interactions | 2.28e-06 | 111 | 208 | 9 | int:KRT35 | |
| Interaction | KRT32 interactions | 5.72e-06 | 44 | 208 | 6 | int:KRT32 | |
| Interaction | PCDHA12 interactions | 7.47e-06 | 46 | 208 | 6 | int:PCDHA12 | |
| Interaction | KRT18 interactions | NES EPPK1 ACLY BIRC6 CEP350 KIF14 KIFC3 TACC3 KRT8 KRT18 KRT81 CNOT10 KRT75 BBS7 SSX2IP EIF3F | 7.82e-06 | 419 | 208 | 16 | int:KRT18 |
| Interaction | KRT36 interactions | 1.13e-05 | 74 | 208 | 7 | int:KRT36 | |
| Interaction | MAP1B interactions | RPL10L EPPK1 PSMB2 MCM4 PHB1 SGK3 CKMT2 FAM120A GLUD1 GLUD2 DYNC1H1 HSP90AB1 HSP90AB3P RARS1 KRT18 HIP1R EIF3F RPL10 | 1.31e-05 | 539 | 208 | 18 | int:MAP1B |
| Interaction | USP53 interactions | 1.36e-05 | 138 | 208 | 9 | int:USP53 | |
| Interaction | HTT interactions | NES ATP6V1B2 PDE1A SPAG1 EPPK1 DIS3L2 ACLY PSMB2 PHB1 GLB1 GLUD1 CLTA MED21 PRMT2 DYNC1H1 HSP90AB1 ROCK2 WFS1 CNOT10 NPEPPS KIF21A USP24 HIP1R LAMP2 GRIN1 | 1.68e-05 | 949 | 208 | 25 | int:HTT |
| Interaction | PCDHA9 interactions | 1.79e-05 | 32 | 208 | 5 | int:PCDHA9 | |
| Interaction | CLK1 interactions | MYOM1 RAPH1 CDH23 FAT1 KIF14 KRT8 PPFIBP2 SPTBN4 MTBP PSME3 HSP90AB2P | 1.81e-05 | 219 | 208 | 11 | int:CLK1 |
| Interaction | ANKRD20A4P interactions | 2.12e-05 | 6 | 208 | 3 | int:ANKRD20A4P | |
| Interaction | PCDHA3 interactions | 2.43e-05 | 34 | 208 | 5 | int:PCDHA3 | |
| Interaction | DNAJB3 interactions | 3.54e-05 | 60 | 208 | 6 | int:DNAJB3 | |
| Interaction | PCDHA4 interactions | 3.54e-05 | 60 | 208 | 6 | int:PCDHA4 | |
| Interaction | CIT interactions | RPL10L NES EPPK1 CLTCL1 HIPK1 EMILIN2 MCM4 BIRC6 PHB1 URB1 DDX46 FAM120A SYNE2 GLUD1 CLTA KIF14 DYNC1H1 HSP90AB1 HSP90AB3P RARS1 NPEPPS PCDHA6 GRIN1 SPTBN4 CELSR2 SMARCA1 CSTF3 INTS4 HSP90AB2P EIF3F FRMD5 RPL10 | 3.64e-05 | 1450 | 208 | 32 | int:CIT |
| Interaction | ANKRD20A2P interactions | 3.68e-05 | 7 | 208 | 3 | int:ANKRD20A2P | |
| Interaction | PCDHGA10 interactions | 3.78e-05 | 19 | 208 | 4 | int:PCDHGA10 | |
| Interaction | KRT19 interactions | BIRC6 KRT80 CEP350 KIFC3 KRT8 KRT18 KRT81 CNOT10 KRT83 KRT86 KRT75 SSX2IP | 3.88e-05 | 282 | 208 | 12 | int:KRT19 |
| Interaction | LTBP1 interactions | 4.70e-05 | 92 | 208 | 7 | int:LTBP1 | |
| Interaction | KRT33B interactions | 5.04e-05 | 93 | 208 | 7 | int:KRT33B | |
| Interaction | UNC45B interactions | 6.97e-05 | 22 | 208 | 4 | int:UNC45B | |
| Interaction | INA interactions | 8.05e-05 | 173 | 208 | 9 | int:INA | |
| Interaction | PCDHA6 interactions | 8.70e-05 | 9 | 208 | 3 | int:PCDHA6 | |
| Interaction | KRT15 interactions | 1.00e-04 | 178 | 208 | 9 | int:KRT15 | |
| Interaction | EPS15 interactions | 1.00e-04 | 220 | 208 | 10 | int:EPS15 | |
| Interaction | NDC80 interactions | KRT27 BIRC6 CEP350 SYNE2 KIF14 KIFC3 GOLGA3 ROCK2 KRT8 HIP1R KRT75 SSX2IP | 1.02e-04 | 312 | 208 | 12 | int:NDC80 |
| Interaction | PDZRN3 interactions | 1.08e-04 | 46 | 208 | 5 | int:PDZRN3 | |
| Interaction | GOLGA1 interactions | 1.24e-04 | 183 | 208 | 9 | int:GOLGA1 | |
| Interaction | ECT2 interactions | RPL10L NES EPPK1 CLTCL1 HSP90AB4P ACLY PHB1 DDX46 FAM120A GLB1 KIF14 MICAL3 KIFC3 DYNC1H1 STOML2 HSP90AB1 NPEPPS SPTBN4 PSME3 HSP90AB2P USP6NL RPL10 | 1.33e-04 | 887 | 208 | 22 | int:ECT2 |
| Interaction | RUFY1 interactions | HSP90AB4P ACLY PHB1 DYNC1H1 STOML2 HSP90AB1 HSP90AB3P RARS1 NPEPPS USP24 LAMP2 EXD2 PSME3 HSP90AB2P RPL10 | 1.34e-04 | 476 | 208 | 15 | int:RUFY1 |
| Interaction | KRT6C interactions | 1.35e-04 | 76 | 208 | 6 | int:KRT6C | |
| Interaction | MOS interactions | 1.56e-04 | 78 | 208 | 6 | int:MOS | |
| Interaction | SPRTN interactions | RPL10L MCM4 PHB1 FAM120A GLB1 DYNC1H1 STOML2 HSP90AB1 HSP90AB3P ROCK2 RARS1 NPEPPS POLH DIS3 DNAJC11 HSP90AB2P RPL10 | 1.59e-04 | 596 | 208 | 17 | int:SPRTN |
| Interaction | RPL23 interactions | RPL10L CDH23 PHB1 KLHL7 KIF14 NOTCH2 PCDHGA9 PCDHB6 PCDHA12 PCDHA8 PDE12 CELSR2 EXD2 BTNL2 PCDHGB4 RPL10 | 1.62e-04 | 540 | 208 | 16 | int:RPL23 |
| Interaction | ANKRD20A1 interactions | 1.68e-04 | 11 | 208 | 3 | int:ANKRD20A1 | |
| Interaction | KRT14 interactions | 1.77e-04 | 192 | 208 | 9 | int:KRT14 | |
| Interaction | KRT7 interactions | 1.79e-04 | 80 | 208 | 6 | int:KRT7 | |
| Interaction | NES interactions | 1.85e-04 | 152 | 208 | 8 | int:NES | |
| Interaction | KRT16 interactions | 2.15e-04 | 197 | 208 | 9 | int:KRT16 | |
| Interaction | ZNF518A interactions | 2.34e-04 | 54 | 208 | 5 | int:ZNF518A | |
| Interaction | KRT76 interactions | 2.34e-04 | 84 | 208 | 6 | int:KRT76 | |
| Interaction | KRT28 interactions | 2.45e-04 | 30 | 208 | 4 | int:KRT28 | |
| Interaction | AKT3 interactions | 2.50e-04 | 85 | 208 | 6 | int:AKT3 | |
| Interaction | NEFL interactions | 2.74e-04 | 161 | 208 | 8 | int:NEFL | |
| Interaction | PRPH interactions | 2.79e-04 | 204 | 208 | 9 | int:PRPH | |
| Interaction | CDKL4 interactions | 2.87e-04 | 13 | 208 | 3 | int:CDKL4 | |
| Interaction | KRT3 interactions | 3.02e-04 | 88 | 208 | 6 | int:KRT3 | |
| Cytoband | 5q31 | PCDHA9 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 8.95e-18 | 115 | 212 | 15 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHA9 DDX46 FNIP1 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 6.73e-14 | 298 | 212 | 17 | chr5q31 |
| Cytoband | 12q13 | 1.01e-06 | 71 | 212 | 6 | 12q13 | |
| Cytoband | 15q15.3 | 2.07e-04 | 25 | 212 | 3 | 15q15.3 | |
| Cytoband | 6q12-q13 | 2.10e-04 | 5 | 212 | 2 | 6q12-q13 | |
| GeneFamily | Clustered protocadherins | PCDHA9 PCDHGA9 PCDHGA3 PCDHB6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGB4 | 5.54e-18 | 64 | 155 | 15 | 20 |
| GeneFamily | Keratins, type II | 9.19e-08 | 27 | 155 | 6 | 609 | |
| GeneFamily | Laminin subunits | 1.28e-04 | 12 | 155 | 3 | 626 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 6.33e-04 | 20 | 155 | 3 | 736 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.41e-04 | 46 | 155 | 4 | 622 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD20A2P ANKRD20A3P ANKRD20A4P PLA2G6 ANKRD20A1 NOTCH2 ANKRD13A MYO16 | 1.17e-03 | 242 | 155 | 8 | 403 |
| GeneFamily | Calcium voltage-gated channel subunits | 1.39e-03 | 26 | 155 | 3 | 253 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.53e-03 | 9 | 155 | 2 | 1234 | |
| GeneFamily | MCM family | 2.53e-03 | 9 | 155 | 2 | 1085 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 EPPK1 KRT27 CACNG2 KRT18 RBP3 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.74e-10 | 261 | 209 | 16 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 EPPK1 KRT27 CACNG2 KRT18 RBP3 PCDHA13 PCDHA12 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.22e-10 | 238 | 209 | 15 | M2020 |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS | ISY1 MLST8 EPN1 HSP90AB1 ROCK2 RARS1 ARHGAP23 HIP1R HIPK2 USF3 CCDC88A RPL10 DNPEP | 6.28e-06 | 356 | 209 | 13 | M43609 |
| Coexpression | DESCARTES_ORGANOGENESIS_PRIMITIVE_ERYTHROID_LINEAGE | HIPK1 ANKRD20A3P ANKRD20A8P SGK3 ANKRD20A4P KIF14 ANKRD20A1 GINS3 ARHGAP23 HIPK2 PKHD1L1 SSX2IP PSME3 EIF3F UEVLD | 1.20e-05 | 497 | 209 | 15 | MM3640 |
| Coexpression | GU_PDEF_TARGETS_DN | 1.61e-05 | 40 | 209 | 5 | M10480 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_UP | 3.34e-05 | 199 | 209 | 9 | M3164 | |
| Coexpression | GAUTAM_EYE_CORNEA_MELANOCYTES | ATP6V1B2 CLTA PRMT2 MICAL3 KIFC3 STOML2 LAMA4 LAMP2 EIF3F RPL10 | 5.02e-05 | 261 | 209 | 10 | M43615 |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.22e-07 | 200 | 212 | 9 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.81e-06 | 183 | 212 | 8 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 3.04e-06 | 185 | 212 | 8 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | LAM-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 3.30e-06 | 187 | 212 | 8 | 4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.43e-06 | 188 | 212 | 8 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 3.43e-06 | 188 | 212 | 8 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 3.57e-06 | 189 | 212 | 8 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.16e-06 | 193 | 212 | 8 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.66e-06 | 196 | 212 | 8 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.84e-06 | 197 | 212 | 8 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 199 | 212 | 8 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.22e-06 | 199 | 212 | 8 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.23e-06 | 154 | 212 | 7 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 158 | 212 | 7 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.14e-05 | 159 | 212 | 7 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 159 | 212 | 7 | 22427ad4ad2e797e4664e7a7b0514094f22a18b2 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 1.14e-05 | 159 | 212 | 7 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.23e-05 | 161 | 212 | 7 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-05 | 162 | 212 | 7 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | Club-club-16|World / Class top | 1.45e-05 | 165 | 212 | 7 | 684f3c4872bd630d3f744f15d57dccfd34e96160 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.50e-05 | 166 | 212 | 7 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 167 | 212 | 7 | 2812353ff66e76f10bd327ceb0e6b009502a5258 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-05 | 167 | 212 | 7 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.56e-05 | 167 | 212 | 7 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 167 | 212 | 7 | d15168f46c1599d9fc68a05a7b822c4b439f2987 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.56e-05 | 167 | 212 | 7 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-05 | 167 | 212 | 7 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-05 | 173 | 212 | 7 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 173 | 212 | 7 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 173 | 212 | 7 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-05 | 175 | 212 | 7 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.19e-05 | 176 | 212 | 7 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-05 | 177 | 212 | 7 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-05 | 179 | 212 | 7 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.44e-05 | 179 | 212 | 7 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 2.53e-05 | 180 | 212 | 7 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 181 | 212 | 7 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.72e-05 | 182 | 212 | 7 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.81e-05 | 183 | 212 | 7 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | mild-B_cell|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.81e-05 | 183 | 212 | 7 | 175aaf8fbbff52eab87d78a49d5ab02cd489c438 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 3.02e-05 | 185 | 212 | 7 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.02e-05 | 185 | 212 | 7 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 185 | 212 | 7 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1 ARHGAP5 TENM4 | 3.12e-05 | 186 | 212 | 7 | b05c394aa3573ba855abc3066739ca193883b0c3 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-05 | 186 | 212 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 186 | 212 | 7 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 186 | 212 | 7 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-05 | 126 | 212 | 6 | 10e1448a03f79965b72922fd83ef51de1b7b474f | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|IPF / Disease state, Lineage and Cell class | 3.23e-05 | 187 | 212 | 7 | 19d6a404fc3651d98a93e3848e372df51a239c57 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-05 | 187 | 212 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.34e-05 | 188 | 212 | 7 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 3.46e-05 | 189 | 212 | 7 | 8030a353473da34ae92429f2d822171a2e94248f | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.58e-05 | 190 | 212 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 3.58e-05 | 190 | 212 | 7 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.58e-05 | 190 | 212 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 3.70e-05 | 191 | 212 | 7 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.70e-05 | 191 | 212 | 7 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.82e-05 | 192 | 212 | 7 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-05 | 192 | 212 | 7 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.95e-05 | 193 | 212 | 7 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.95e-05 | 193 | 212 | 7 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.95e-05 | 193 | 212 | 7 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.95e-05 | 193 | 212 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.22e-05 | 195 | 212 | 7 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.22e-05 | 195 | 212 | 7 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | distal-Endothelial-Lymphatic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.22e-05 | 195 | 212 | 7 | f45c1349932ee7eb419cced8a4fdedae3610953f | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-05 | 195 | 212 | 7 | fdbb4abc0c79a6aeace71bfa5a5c5576ca39d758 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 4.36e-05 | 196 | 212 | 7 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.50e-05 | 197 | 212 | 7 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-05 | 197 | 212 | 7 | 06e17c9ad53463eee1007280b3f3e8b0cf446cdc | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.50e-05 | 197 | 212 | 7 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-05 | 198 | 212 | 7 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.64e-05 | 198 | 212 | 7 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.64e-05 | 198 | 212 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-05 | 198 | 212 | 7 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.64e-05 | 198 | 212 | 7 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | RAPH1 ANKRD20A2P ANKRD20A3P CHRNA7 ANKRD20A4P ANKRD20A1 GRIN1 | 4.64e-05 | 198 | 212 | 7 | da84c76afe835aeee39da04b63c03549218b5d91 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-05 | 198 | 212 | 7 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | RAPH1 ANKRD20A2P ANKRD20A3P CHRNA7 ANKRD20A4P ANKRD20A1 GRIN1 | 4.64e-05 | 198 | 212 | 7 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.64e-05 | 198 | 212 | 7 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.79e-05 | 199 | 212 | 7 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 4.79e-05 | 199 | 212 | 7 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 199 | 212 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.79e-05 | 199 | 212 | 7 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 199 | 212 | 7 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 199 | 212 | 7 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.79e-05 | 199 | 212 | 7 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.79e-05 | 199 | 212 | 7 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-05 | 200 | 212 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-05 | 200 | 212 | 7 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-05 | 200 | 212 | 7 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.95e-05 | 200 | 212 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.95e-05 | 200 | 212 | 7 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.95e-05 | 200 | 212 | 7 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.95e-05 | 200 | 212 | 7 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 157 | 212 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 157 | 212 | 6 | 2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5 | |
| Disease | 1,5 anhydroglucitol measurement | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.33e-17 | 29 | 194 | 11 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.35e-11 | 87 | 194 | 11 | EFO_0004340, EFO_0004765 |
| Disease | neuroticism measurement, cognitive function measurement | PDE1A PCDHA9 BIRC6 FCHO1 FAM120A SEMA6D PLCL2 CACNA1C PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CDH12 | 7.64e-09 | 566 | 194 | 19 | EFO_0007660, EFO_0008354 |
| Disease | post-traumatic stress disorder symptom measurement | 7.10e-08 | 82 | 194 | 8 | EFO_0008535 | |
| Disease | MONILETHRIX | 2.80e-07 | 3 | 194 | 3 | 158000 | |
| Disease | Beaded hair | 2.80e-07 | 3 | 194 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 2.80e-07 | 3 | 194 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | neutrophil count, basophil count | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.08e-07 | 224 | 194 | 11 | EFO_0004833, EFO_0005090 |
| Disease | Monilethrix | 1.11e-06 | 4 | 194 | 3 | C0546966 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 5.52e-06 | 6 | 194 | 3 | DOID:1825 (biomarker_via_orthology) | |
| Disease | mean reticulocyte volume | ATR RAPH1 MCM4 CEP350 CD82 PLCL2 SLC35E4 TACC3 HSP90AB1 KRT8 ZFAT NPEPPS TTC7A SLC22A3 MAST1 INTS4 EIF3F MYO16 | 6.21e-06 | 799 | 194 | 18 | EFO_0010701 |
| Disease | post-traumatic stress disorder | FAM120A PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.25e-06 | 202 | 194 | 9 | EFO_0001358 |
| Disease | Abnormality of refraction | PCDHA9 BIRC6 PIK3R4 GALNT8 PLA2G6 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 EXD2 | 1.07e-05 | 673 | 194 | 16 | HP_0000539 |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.94e-05 | 50 | 194 | 5 | DOID:3770 (biomarker_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 3.78e-05 | 29 | 194 | 4 | DOID:767 (biomarker_via_orthology) | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 4.30e-05 | 2 | 194 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Cirrhosis, Familial | 4.30e-05 | 2 | 194 | 2 | C1861556 | |
| Disease | hair disease (is_implicated_in) | 4.30e-05 | 2 | 194 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Pneumoconiosis | 9.66e-05 | 14 | 194 | 3 | C0032273 | |
| Disease | Bagassosis | 9.66e-05 | 14 | 194 | 3 | C0004681 | |
| Disease | pancreatitis (biomarker_via_orthology) | 1.24e-04 | 39 | 194 | 4 | DOID:4989 (biomarker_via_orthology) | |
| Disease | T-cell acute lymphoblastic leukemia (implicated_via_orthology) | 1.28e-04 | 3 | 194 | 2 | DOID:5603 (implicated_via_orthology) | |
| Disease | fascioliasis (biomarker_via_orthology) | 1.28e-04 | 3 | 194 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | depressive symptom measurement | TOPAZ1 FAM120A SEMA6D SYNE2 PLCL2 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.30e-04 | 426 | 194 | 11 | EFO_0007006 |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.38e-04 | 40 | 194 | 4 | EFO_0004746 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 1.41e-04 | 228 | 194 | 8 | EFO_0003948, MONDO_0004975 | |
| Disease | autistic disorder (implicated_via_orthology) | 2.56e-04 | 4 | 194 | 2 | DOID:12849 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | ACE CHRNA7 PLA2G6 CACNA1C CNTN4 WFS1 HIP1R PHETA1 GRIN1 TENM4 RIMS1 | 3.42e-04 | 477 | 194 | 11 | C0005586 |
| Disease | Autistic Disorder | 3.52e-04 | 261 | 194 | 8 | C0004352 | |
| Disease | Respiratory Syncytial Virus Infections | 4.24e-04 | 5 | 194 | 2 | C0035235 | |
| Disease | Hypoplastic Left Heart Syndrome | 4.24e-04 | 5 | 194 | 2 | C0152101 | |
| Disease | follicular lymphoma (implicated_via_orthology) | 4.24e-04 | 5 | 194 | 2 | DOID:0050873 (implicated_via_orthology) | |
| Disease | mental development measurement | 5.78e-04 | 25 | 194 | 3 | EFO_0008230 | |
| Disease | cognitive disorder (implicated_via_orthology) | 6.34e-04 | 6 | 194 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | age at diagnosis, substance-related disorder | 6.34e-04 | 6 | 194 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | body mass index, vital capacity | 6.34e-04 | 6 | 194 | 2 | EFO_0004312, EFO_0004340 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 6.34e-04 | 6 | 194 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.20e-04 | 291 | 194 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | Congenital Pain Insensitivity | 8.84e-04 | 7 | 194 | 2 | C0002768 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 8.84e-04 | 7 | 194 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | female breast cancer (is_implicated_in) | 1.17e-03 | 8 | 194 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 1.17e-03 | 8 | 194 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | triacylglycerol 58:10 measurement | 1.44e-03 | 34 | 194 | 3 | EFO_0010437 | |
| Disease | pancreatic adenocarcinoma (is_marker_for) | 1.87e-03 | 10 | 194 | 2 | DOID:4074 (is_marker_for) | |
| Disease | neutrophil count | NES PCDHA9 CDH23 FCHO1 NOTCH2 SEMA6C ARHGAP23 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ANKRD13A HELLS | 2.00e-03 | 1382 | 194 | 19 | EFO_0004833 |
| Disease | liver cirrhosis (is_marker_for) | 2.12e-03 | 82 | 194 | 4 | DOID:5082 (is_marker_for) | |
| Disease | Graves' disease (is_implicated_in) | 2.15e-03 | 39 | 194 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | pulse pressure measurement | PDE1A PCDHA9 RAPH1 PIK3R4 CORO7 ZFAT PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SPTBN4 TENM4 SLC22A3 | 2.16e-03 | 1392 | 194 | 19 | EFO_0005763 |
| Disease | Berylliosis | 2.27e-03 | 11 | 194 | 2 | C0005138 | |
| Disease | Beryllium Disease | 2.27e-03 | 11 | 194 | 2 | C2350873 | |
| Disease | forced expiratory volume, body mass index | 2.27e-03 | 11 | 194 | 2 | EFO_0004314, EFO_0004340 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.72e-03 | 12 | 194 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 2.72e-03 | 12 | 194 | 2 | EFO_0008141 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 2.85e-03 | 43 | 194 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | triglycerides in large LDL measurement | 2.85e-03 | 43 | 194 | 3 | EFO_0022319 | |
| Disease | liver cirrhosis (is_implicated_in) | 2.85e-03 | 43 | 194 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | Disorder of eye | 2.87e-03 | 212 | 194 | 6 | C0015397 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.10e-03 | 91 | 194 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 3.20e-03 | 13 | 194 | 2 | C0751122 | |
| Disease | vital capacity | PCDHA9 DIS3L2 MICAL3 ZFAT PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ODAD2 HSP90AB2P MYO16 | 3.41e-03 | 1236 | 194 | 17 | EFO_0004312 |
| Disease | total lipids in small LDL | 3.67e-03 | 47 | 194 | 3 | EFO_0022168 | |
| Disease | free cholesterol in medium VLDL measurement | 3.67e-03 | 47 | 194 | 3 | EFO_0022269 | |
| Disease | triacylglycerol 48:4 measurement | 3.72e-03 | 14 | 194 | 2 | EFO_0010407 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.84e-03 | 225 | 194 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | schizophrenia, anorexia nervosa | 3.89e-03 | 48 | 194 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | total lipids in lipoprotein particles measurement | 3.89e-03 | 48 | 194 | 3 | EFO_0022309 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 4.27e-03 | 15 | 194 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Tourette syndrome | 4.37e-03 | 50 | 194 | 3 | EFO_0004895 | |
| Disease | Psychotic Disorders | 4.50e-03 | 101 | 194 | 4 | C0033975 | |
| Disease | sarcoidosis (is_implicated_in) | 4.86e-03 | 16 | 194 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | phospholipids in medium VLDL measurement | 4.88e-03 | 52 | 194 | 3 | EFO_0022154 | |
| Disease | cholesterol in small VLDL measurement | 5.15e-03 | 53 | 194 | 3 | EFO_0022228 | |
| Disease | total lipids in medium VLDL | 5.43e-03 | 54 | 194 | 3 | EFO_0022153 | |
| Disease | Antibody Deficiency Syndrome | 5.48e-03 | 17 | 194 | 2 | C0003257 | |
| Disease | Psychoses, Substance-Induced | 5.48e-03 | 17 | 194 | 2 | C0033941 | |
| Disease | Nuclear non-senile cataract | 6.14e-03 | 18 | 194 | 2 | C1112705 | |
| Disease | Nuclear cataract | 6.14e-03 | 18 | 194 | 2 | C0392557 | |
| Disease | autoimmune thyroid disease, type 1 diabetes mellitus | 6.14e-03 | 18 | 194 | 2 | EFO_0006812, MONDO_0005147 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLEADIESYQSRLAA | 601 | Q5TYW2 | |
| DASYSLILEVQTAID | 391 | Q8IWZ6 | |
| VAIADYAATDETQLS | 36 | P55345 | |
| RLEADIESYQSRLAA | 601 | Q5CZ79 | |
| SRLLDYVATVEDEAA | 2176 | Q9NR09 | |
| STQDTVIALDALSAY | 1301 | P0C0L5 | |
| YASNAVSEALIREVA | 391 | Q9ULA0 | |
| DRVTNDTESDINYLL | 441 | P12821 | |
| YAEATLVVRNASAES | 201 | Q9UIR0 | |
| SELSRAQEKALDTSY | 1331 | O14514 | |
| QQLATAYDDDTTSLL | 406 | Q9Y2D8 | |
| RLEADIESYQSRLAA | 601 | Q4UJ75 | |
| NYSEAEIKVREATSN | 16 | Q9H201 | |
| QDTAEYLLRAVRASS | 91 | O60359 | |
| VLASADASRYVFRNE | 751 | Q8IWV2 | |
| TLEVRDLNYQVDLAS | 46 | Q9H221 | |
| EDQVSYTLAITARDN | 776 | Q9HCU4 | |
| ISELQQYADVAAARE | 1176 | Q9Y4B4 | |
| QYADVAAARESRQSS | 1181 | Q9Y4B4 | |
| SDLDKVAAERATSVY | 421 | Q8IYB7 | |
| RESQAVYSLILVASD | 2681 | Q9H251 | |
| DILLYNSADERFDAT | 111 | P36544 | |
| ALSRYATALEDTVDT | 291 | Q6UXT9 | |
| VTELIRDYNSSREDS | 121 | P27701 | |
| LEAAEDIAYQLSRSR | 241 | P35232 | |
| YSLDDVTAQLEQASL | 151 | Q70E73 | |
| DADAQENALVSYSLV | 481 | Q9Y5H5 | |
| EDDQYSLVASLDNVR | 11 | O60671 | |
| LSDDYEQVRSAAVQL | 241 | Q96HW7 | |
| ASDLEQRELSSYVSI | 491 | Q9UN71 | |
| SALDRESVSAYELVV | 411 | Q9Y5H9 | |
| DADAQENALVSYSLV | 481 | Q9Y5H9 | |
| SALDRESVSAYELVV | 411 | Q9UN73 | |
| DADAQENALVSYSLV | 481 | Q9UN73 | |
| QYEDIANRSRAEAES | 266 | P05787 | |
| AARSYDLSDITQADL | 61 | O75427 | |
| ERLEATEYLVSAAEA | 116 | Q9H2D1 | |
| RLEADIESYQSRLAA | 601 | Q5SQ80 | |
| DAQYERAIQESLLTS | 521 | Q8IZ07 | |
| ADTAEYFLRAVRASS | 91 | Q9Y698 | |
| IALSIEATAADVEAY | 991 | Q8TAB3 | |
| SALDRESVSAYELVV | 411 | Q9UN72 | |
| AAESLRRSVEKYNSA | 171 | O14526 | |
| QVYAASRDIEANAEI | 3251 | Q14517 | |
| RLSEEASQALIEAYV | 701 | P33991 | |
| ESNSLALVYRDRETL | 496 | Q8N543 | |
| SLDAATEVSRAEVTY | 6101 | Q8WXI7 | |
| AEDSSANIITDLVYQ | 1851 | Q04721 | |
| YSLLNVRREASSEEL | 16 | Q9NVH1 | |
| NASDALDKIRYESLT | 46 | P08238 | |
| AASNIEETLSTLRYA | 681 | Q15058 | |
| DADAQENALVSYSLV | 481 | Q9Y5H6 | |
| DADAQENALVSYSLV | 481 | Q9Y5H8 | |
| INLTAADTVIIYDSD | 681 | Q9NRZ9 | |
| DTLEAASYLQVTEAL | 101 | Q8N239 | |
| LASYLDRVRSLETEN | 91 | P05783 | |
| SRENVDQEALLSYAR | 326 | Q7RTP6 | |
| ILARLSTESADDYNF | 246 | Q9H2X6 | |
| LSTEAARVLQDFYLE | 681 | Q9UJA3 | |
| YDALVIQNASDIARE | 1196 | Q9Y6X6 | |
| SILSRLSSENADEYN | 236 | Q86Z02 | |
| NYSEAEIKVREATSN | 16 | O95208 | |
| NASDALDKIRYESLT | 46 | Q58FF8 | |
| NASDALDKIRYESLT | 46 | Q58FF7 | |
| SNASDALDKIRYESL | 21 | Q58FF6 | |
| KYASETLQAQSEEAR | 266 | Q9ULR0 | |
| TLTINSLEAEDAATY | 91 | A0A0C4DH24 | |
| QYDDIVTRSRAEAES | 281 | O43790 | |
| QVEAYQAEAREALAT | 866 | Q9BY66 | |
| AVAARSLEEAEAYSR | 261 | Q6KB66 | |
| EAYSRSQLEEQAARS | 271 | Q6KB66 | |
| TEAVASSLYDILARG | 286 | P16278 | |
| AANVLASSSYDLTVR | 606 | P57737 | |
| IAALEARLEESTNYN | 976 | Q3V6T2 | |
| DAETLTEDQVIYAAR | 231 | Q9NVH0 | |
| TEDQVIYAARDAQIS | 236 | Q9NVH0 | |
| DSQYIVTASSDNLAR | 281 | Q9BVC4 | |
| TLTINSLEAEDAAAY | 91 | A0A0A0MT36 | |
| SNENSRVIYSLAEDT | 481 | Q9Y5G4 | |
| TAASLDRERIAEYNL | 451 | O95206 | |
| EDALIRTVSYNILAD | 291 | Q6L8Q7 | |
| SDVAILYNDRSVLEN | 276 | P54750 | |
| SDEAANIYERAISTL | 321 | Q12996 | |
| TEEYAQLFAALIART | 51 | Q13503 | |
| SLEVATYRTLLEAEN | 296 | P48681 | |
| ASYLENVRALEEANA | 96 | Q7Z3Y8 | |
| SYALELNLTDSENAT | 26 | P13473 | |
| QDTLTVRAEDQVYDA | 196 | Q8IXQ5 | |
| RSSNNFDYILAADVV | 186 | A6NDL7 | |
| VADYVRNIQDTSDLD | 286 | Q9NZB2 | |
| SADYTRAQELDALDN | 401 | A6NEC2 | |
| LVLDSALDRESVSVY | 406 | Q9Y5H7 | |
| SKIRSLADYRTEDSN | 241 | Q08378 | |
| AASNETYQERLARLE | 101 | Q8ND30 | |
| LQDAYERSESLEVAF | 256 | Q9Y2H9 | |
| SADYVLSVRDTQAVR | 111 | Q13882 | |
| DADAQENALVSYSLV | 481 | Q9Y5I3 | |
| SALDRESVSAYELVV | 411 | Q9Y5I0 | |
| DADAQENALVSYSLV | 481 | Q9Y5I0 | |
| RDVDSQYLSEQDSEL | 1006 | Q86UR5 | |
| DREQISEYNISLRAS | 411 | Q9Y5H0 | |
| SQDYTEALRAARELA | 1086 | Q9UHC9 | |
| SALDRESVSAYELVV | 411 | Q9UN74 | |
| DADAQENALVSYSLV | 481 | Q9UN74 | |
| SYISDELELDLASRS | 356 | Q8N878 | |
| DSNERVAVIADEAYS | 411 | Q7Z6J6 | |
| RLEADIESYQSRLAA | 601 | Q5VUR7 | |
| SRAQDSAAYAIQELL | 1411 | Q13535 | |
| YLVSRAQEALDAVST | 656 | O75146 | |
| LLDFAYSSRIAINEE | 101 | Q9H0H3 | |
| YSSRIAINEENAESL | 106 | Q9H0H3 | |
| DSNATNSNLERVEYL | 151 | Q13936 | |
| YNVADFESLSRIVDD | 1356 | Q99715 | |
| DALSTVLQYAEDVLS | 281 | O00303 | |
| RYSTDVSVDEVKALA | 151 | P00367 | |
| LYVGQLIAEASASDR | 541 | Q9NY28 | |
| ADASQRSLAYNRIVD | 381 | Q8TF40 | |
| TARANVYVTENADIA | 221 | O43909 | |
| DLGSYIANVTRAAEV | 361 | Q2M3T9 | |
| AELSYLNAIEESVRQ | 1331 | Q5VT06 | |
| STQLARALYDNTAES | 6 | O43281 | |
| VLNYDKATDIEESSR | 321 | A6NNE9 | |
| NYSEAEIKVREATSN | 16 | Q9Y6I3 | |
| DIARTEYLSNADERL | 3546 | Q14204 | |
| ADSNLEETLSTLRYA | 316 | Q2VIQ3 | |
| TREATQAEIEADRSY | 831 | Q13753 | |
| IATNELLDRESTAQY | 441 | P55289 | |
| ERDAYVEAVLSVSNA | 961 | Q9BXX0 | |
| SKEALQRISEYSEAA | 951 | Q7L014 | |
| SYENLSRDVDEVAQL | 106 | Q8TB52 | |
| ALARQSLESYLSDYE | 941 | Q92622 | |
| QRYLLEAANDSASAT | 91 | O75751 | |
| SDYSIVNASVLEADD | 466 | Q96BR1 | |
| SADYTRAQELDALDN | 401 | P55786 | |
| SSDEYQAARATLLRA | 1176 | Q9C0B2 | |
| RYSTDVSVDEVKALA | 151 | P49448 | |
| STQDTVIALDALSAY | 1301 | P0C0L4 | |
| QYDDIATRSRAEAES | 286 | P78385 | |
| AEYLSANVVSLEDLR | 216 | Q96DY7 | |
| SALDRESVSAYELVV | 411 | Q9UN75 | |
| AEFALNTTDRIYDAV | 641 | Q16363 | |
| TAAVADVYDISNIDR | 361 | P17540 | |
| ALDRESRAEYNITIT | 406 | Q9Y5E3 | |
| DLDITSNTVRVLAAY | 141 | A6NHM9 | |
| SNTVRVLAAYGLDDT | 146 | A6NHM9 | |
| ASDEEVYTAAREANA | 576 | Q9NUT2 | |
| EYEQLSSEALEAARI | 56 | Q96L21 | |
| LTAEELNAAQTSVAY | 486 | P54136 | |
| SSYAEALREVSAARE | 301 | P21281 | |
| SYAEALREVSAAREE | 296 | P15313 | |
| AVEENLSSYSLDRRV | 181 | Q9Y6A5 | |
| TRARTYVLAAESQDA | 86 | Q8N4B1 | |
| INLASADVVILYDSD | 581 | P28370 | |
| YRLTTIAVDQVDAAD | 461 | Q13275 | |
| NRSFDIDAIYSVIDD | 321 | Q8N7P1 | |
| AYNEDTSALVARLDE | 156 | Q9BRX5 | |
| VLRDFQEYLAAVESS | 2521 | Q8WXH0 | |
| DAYTVELENAESRVA | 4676 | Q8WXH0 | |
| EYEQLSSEALEAARI | 56 | P27635 | |
| RVTVADYADSDLAVV | 36 | Q1AE95 | |
| TVSAAEIYNEVLRDL | 571 | Q9BVG8 | |
| RATAQALYQLSEDAD | 981 | Q5T2S8 | |
| ALYRLESVSLDIASS | 681 | P25391 | |
| YESLDLVANSADVAN | 226 | Q9UPR0 | |
| SSYLSEARRDELLAQ | 3196 | P58107 | |
| DYVLVASDRVAASNI | 11 | P49721 | |
| EAEAIAAAAAEYTSI | 436 | Q15858 | |
| QLREAYATATAEVLA | 131 | A6NM43 | |
| QLREAYATATAEVLA | 131 | Q96SF2 | |
| RASIDEAYVDLTSAV | 111 | Q9Y253 | |
| EVAVADYTSSDRVRE | 26 | O60733 | |
| ANEIRTQSTDDEYAL | 611 | Q13017 | |
| ASLTYAEAQLRIDSA | 586 | Q9Y2L1 | |
| TALLQAAYESQALRD | 891 | O60287 | |
| LLANDSVLAAIRDYS | 821 | Q7RTU9 | |
| NATAALVELDREVNY | 61 | P0CW24 | |
| SVDLAARYESAAVIL | 176 | Q5VST6 | |
| VDVLINFASLRSAYD | 566 | P53396 | |
| AQDSSLAYERAFLAV | 101 | Q5TBC7 | |
| RLDNYDALDIASIAV | 1046 | P53675 | |
| DALDIASIAVSSALY | 1051 | P53675 | |
| TDSYAAISQVDRLQS | 91 | P09496 | |
| YAAEALISLDRISDA | 576 | Q9H9A5 | |
| TVAELRTVESEAASY | 161 | P61289 | |
| RTVESEAASYLDQIS | 166 | P61289 | |
| AQDDATIVRLAYAEN | 471 | Q99570 | |
| TESYVQAASDASRAI | 56 | Q8IWX7 | |
| SGASVEEALERAYSQ | 561 | Q92738 | |
| AAVAALQDLRYTSES | 1106 | Q9P243 | |
| YASKDLEEQLRSVSS | 51 | P49767 | |
| GAYRTAVDLESLASQ | 671 | P10745 | |
| SLTANIDYINDSISD | 991 | Q7Z4S6 | |
| SRDTLEAATSLYDRV | 426 | Q96PX9 | |
| LLDASAVSATSRYIE | 136 | O60499 | |
| VAYQEAVRTLSSRDD | 116 | Q8IUC6 | |
| SDDYLSRATRSAEAL | 351 | Q9P227 | |
| ATSDNDNSYARVRAV | 6 | Q7Z699 | |
| EIADDLSILYSNRAA | 481 | Q07617 | |
| TLSLAVREDYLDNST | 226 | P78562 | |
| QLARSIAEEQYSDLE | 926 | O75116 | |
| SSETLKAYDQDARLA | 41 | Q6N022 | |
| AADFQASDAVVYRSL | 191 | Q9H3T2 | |
| YARIVAASEALLAAD | 1146 | Q9H254 | |
| ERNRVSSYSAEALIG | 1661 | Q68DE3 | |
| DAAASLTVAEQYVSA | 271 | Q9UJZ1 | |
| ESYTLAADVGILSRN | 3246 | Q86WI1 | |
| RAQAEDYALVSAVAT | 441 | Q96GW9 | |
| TRLQAENSELSREYE | 441 | Q9H6N6 | |
| SSSDINILYNDAVES | 296 | O60290 | |
| SRSNDDYQAAVERLI | 1626 | Q8N9V7 | |
| QDVAADLKTRYLSAT | 231 | O96014 | |
| SAQDTLAYATALLNE | 2561 | Q9UPU5 | |
| SSDEARQVDLLAYIA | 146 | Q8IX04 | |
| DRTVSLQNAAAIYDL | 371 | Q9ULT0 | |
| QEERLDAVTLLYATS | 211 | Q6ICL7 | |
| LLANDSVLAAIRDYS | 821 | A6NGW2 | |
| YDSSEEAIRTLDQIS | 366 | Q6PGP7 | |
| DRLTRNSVYDSNLEA | 141 | P0CG31 | |
| ATVADFLASDAVIYR | 186 | Q8NFY4 | |
| VRDENSSVYAEVSRL | 6 | Q8NG68 | |
| YVRVTDIDNSAESAI | 706 | O76024 | |
| QYEDIANRSRAEAES | 326 | O95678 | |
| ALSNYRDINIDDETV | 556 | Q96M32 | |
| QYDDIVTRSRAEAES | 281 | Q14533 | |
| EAAAYIAQRNLLASE | 161 | P52179 | |
| LSASEDDAATVYRAA | 221 | Q05586 |